Vitamin K Antagonist Use and Level of Anticoagulation Control Among Patients at a Tertiary Hospital in Northern Tanzania

Vitamin K Antagonist Use and Level of Anticoagulation Control Among Patients at a Tertiary Hospital in Northern Tanzania

Background Vitamin K antagonists (VKA) continue to be the principal anticoagulants for both the treatment and prevention of venous thromboembolism. The use of VKA often requires regular monitoring to avoid over-anticoagulation and prevent thromboembolic complications. The aim was to determine the in...

Full description

Saved in:
Bibliographic Details
Main Authors: Sarah K. Gharib MMed, Abid M. Sadiq MMed, Faryal M. Raza MMed, Sophia S. Muhali MMed, Annette A. Marandu MMed, Norman J. Kyala MMed, Eliasa K. Ndale MMed, Venance P. Maro MMed, William P. Howlett PhD, Elifuraha W. Mkwizu MMed, Nyasatu G. Chamba PhD, Furaha S. Lyamuya MMed, Elichilia R. Shao MMed, Kajiru G. Kilonzo MPhil
Format: Article
Language:English
Published: SAGE Publishing 2025-01-01
Series:Journal of Cardiovascular Pharmacology and Therapeutics
Online Access:https://doi.org/10.1177/10742484251315104
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doi.org/10.1177/10742484251315104

Similar Items